ALLIANCEBERNSTEIN L.P. - ZENTALIS PHARMACEUTICALS INC ownership

ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 105 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.3%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of ZENTALIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,157,823
-96.9%
57,718
-95.6%
0.00%
-100.0%
Q2 2023$37,277,681
+68.0%
1,321,435
+2.4%
0.02%
+50.0%
Q1 2023$22,193,091
-19.3%
1,290,296
-5.5%
0.01%
-16.7%
Q4 2022$27,501,130
-4.7%
1,365,498
+2.5%
0.01%
-14.3%
Q3 2022$28,849,000
-24.2%
1,331,884
-1.7%
0.01%
-17.6%
Q2 2022$38,060,000
-17.2%
1,354,463
+35.9%
0.02%
-5.6%
Q1 2022$45,990,000
-41.0%
996,759
+7.5%
0.02%
-35.7%
Q4 2021$77,918,000
+18.6%
926,937
-6.0%
0.03%
+7.7%
Q3 2021$65,704,000
+31.3%
985,953
+4.8%
0.03%
+30.0%
Q2 2021$50,052,000
+4.4%
940,828
-14.9%
0.02%
-4.8%
Q1 2021$47,958,000
+10.7%
1,105,282
+32.5%
0.02%
+5.0%
Q4 2020$43,341,000
+72.0%
834,448
+8.3%
0.02%
+42.9%
Q3 2020$25,196,000
+5.3%
770,770
+54.7%
0.01%0.0%
Q2 2020$23,927,000498,2720.01%
Other shareholders
ZENTALIS PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Mayo Clinic 362,459$15,727,096,00018.11%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 2,664,409$115,609,0002.54%
Matrix Capital Management Company, LP 3,821,739$165,825,0001.92%
Avidity Partners Management LP 1,263,300$54,815,0001.51%
Redmile Group, LLC 2,221,044$96,371,0001.36%
Affinity Asset Advisors, LLC 77,500$3,363,0001.14%
SPHERA FUNDS MANAGEMENT LTD. 175,140$7,599,0000.58%
Eventide Asset Management 832,000$36,100,0000.54%
Integral Health Asset Management, LLC 40,000$1,736,0000.50%
VIKING GLOBAL INVESTORS LP 2,399,284$104,105,0000.31%
View complete list of ZENTALIS PHARMACEUTICALS INC shareholders